September 26, 2016 6:04 AM ET

Life Sciences Tools and Services

Company Overview of DSM Biomedical B.V.

Company Overview

DSM Biomedical B.V. operates as a life sciences and biomaterials sciences company. The company manufactures biomedical materials for short and long-term implantable medical devices. The company is based in Heerlen, the Netherlands. DSM Biomedical B.V. operates as a subsidiary of Royal DSM N.V.

Het Overloon 1

Heerlen,  6411 TE

Netherlands

Phone:

31 464 76 35 20

Fax:

31 464 76 35 63

Key Executives for DSM Biomedical B.V.

President
Compensation as of Fiscal Year 2016.

DSM Biomedical B.V. Key Developments

Royal DSM Appopints Eric Teutsch as President of DSM Biomedical

Royal DSM announced Mr. Eric Teutsch's appointment as President of DSM Biomedical effective 16 February 2016. Mr. Teutsch succeeds Mr. Gerard de Reuver who served as the company's interim president since November 2015. As president, Mr. Teutsch will oversee the strategic development and execution of DSM Biomedical's global activities. Under his leadership, DSM Biomedical will continue to strengthen existing technology platforms and will explore opportunities to form strategic partnerships that complement its activities in the medical device market.

DSM Partners with Vention Medical to Provide Single-Source Solution for Catheters and Coatings

DSM Biomedical announced a partnership with Vention Medical to provide customers who develop and manufacture coated medical devices with a single-source offering. The partnership offers customers the option to integrate the development, testing and application of DSM’s ComfortCoat® coating into the catheter manufacturing process, eliminating the need to transfer finished products to another supplier for development and coating application services. Medical device manufacturers continue to improve clinical outcomes while being pressured, like never before, to further reduce costs. This is best achieved by designing innovative products for manufacturing, reducing time to market, and leveraging an integrated and consolidated supply chain. DSM’s innovative ComfortCoat coating can help improve performance and patient comfort when applied to medical devices, such as catheters. ComfortCoat coating helps device navigation and mitigates risks of acute trauma to the patient. The collaboration with Vention Medical enables device manufacturers to seamlessly integrate the coating design and production into their devices – optimizing the design and manufacturing efficiency. DSM’s materials scientists and applications engineers will now start to work alongside Vention Medical’s device designers and operations personnel to produce coated catheters. This partnership now enables devices being designed, assembled, coated, and packaged under one single quality system and under one roof. In doing so, work in process is kept to a minimum, supply chain is streamlined, and quality control is optimized. This collaboration offers device manufacturers an unmatched level of service and expertise – from raw materials science and technology innovation to component and device manufacturing, to operations management. This collective and integrated supply chain, on a global manufacturing and sourcing platform, enables DSM and Vention Medical the capability of bringing significant efficiencies to medical device companies.

DSM Biomedical Receives FDA 510K Clearance for Dyneema Purity Radiopaque Cerclage Cable for Use in Orthopedic Trauma

DSM Biomedical announced that the U.S. Food and Drug Administration has cleared the Dyneema Purity Radiopaque Cerclage Cable for use in orthopedic trauma treatments, such as treatment of bone and spine fractures. The Dyneema Purity Radiopaque Cerclage Cable, the first device fully designed and developed by The company’s Polyethylenes Team to receive 510k clearance from the FDA, marks a milestone for the company. The company sought 510k clearance to support the company’s customers in bringing their medical devices for use in orthopedic trauma to market. The cerclage cable is made out of Dyneema Purity Radiopaque fiber, the only radiopaque ultra high molecular weight polyethylene medical fiber in the world. While there are currently other polymeric cerclage cables in the market, these are not radiopaque and therefore cannot be visualized during and after surgical intervention. Dyneema Purity Radiopaque fiber is 15 times stronger than steel while maintaining high pliability and increased flexibility, which may help lower the risk of bone damage. The fiber is biocompatible and chemically inert, which can help reduce tissue inflammation, irritation and complications associated with metal allergies. When using steel cables, both ends of the cable must be guided through a tensioning device, and once fixation is complete, no incremental adjustments are possible. Re-adjustment can only be accomplished by cutting the cable and starting all over again.

Similar Private Companies By Industry

Company Name Region
Ampha B.V. Europe
Applikon Biotechnology B.V. Europe
Ascor Analyse Europe
Batavia Bioservices B.V. Europe
Brain Technology Institute Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DSM Biomedical B.V., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.